HBM Holdings Limited (FRA:6XY)
1.480
-0.020 (-1.33%)
At close: Dec 4, 2025
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| Molecule License Fee - Upfront Payment | 165.32M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Molecule License Fee - Milstone Payment | 66.89M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Research Service Fee | 54.24M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Research Service Fee Growth | 118.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Technology License Fee | 10.85M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Technology License Fee Growth | 82.05% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Molecule License Fee | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Molecule License Fee Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Platform-based Research Fee | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Platform-based Research Fee Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| Europe | 152.52M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 6907.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 78.01M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -87.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 59.69M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -28.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 7.07M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 360.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|